Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study

SC Doebar, EC van den Broek, Linetta Koppert, Agnes Jager, Margreet Baaijens, Inge-marie Obdeijn, Carolien van Deurzen

Research output: Contribution to journalArticleAcademicpeer-review

35 Citations (Scopus)
3 Downloads (Pure)

Abstract

Ductal carcinoma in situ (DCIS) is a precursor of invasive breast carcinoma (IBC). The DCIS component is often more extensive than the invasive component, which affects local control. The aim of our study was to analyze features of DCIS within different IBC subtypes, which may contribute to the optimization of personalized approaches for patients with IBC. Patients with IBC reported according to the synoptic reporting module in the Netherlands between 2009 and 2015 were included. Data extraction included characteristics of the invasive component and, if present, several features of the DCIS component. Resection margin status analyses were restricted to patients undergoing breast-conserving surgery (BCS). Differences between subtypes were tested by a Chi-square test, spearman's Rho test or a one-way ANOVA test. Overall, 36.937 cases of IBC were included. About half of the IBCs (n = 16.014; 43.4 %) were associated with DCIS. Her2+ IBC (irrespective of ER status) was associated with a higher prevalence of adjacent DCIS, a larger extent of DCIS and a higher rate of irradicality of the DCIS component as compared to ER+/Her2- and triple-negative subtypes (P < 0.0001 for all variables). The prevalence of DCIS in triple-negative IBC on the other hand was lowest. In this large population-based cohort study, we showed significant differences between the prevalence and extent of DCIS according to IBC subtypes, which is also reflected in the resection margin status in patients treated with BCS. Our data provide important information regarding the optimization of local therapy according to IBC subtypes.
Original languageUndefined/Unknown
Pages (from-to)179-187
Number of pages9
JournalBreast Cancer Research and Treatment
Volume158
Issue number1
DOIs
Publication statusPublished - 2016

Cite this